Clinical Trial Update: Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study [Phase 2]

View source ↗

Summary

A Phase II single-arm trial is evaluating liposomal irinotecan with 5-FU/leucovorin and bevacizumab as second-line therapy for advanced colorectal cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Leucovorin (folinic acid)
• Onivyde (liposomal irinotecan) (liposomal irinotecan)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Colorectal Cancer (CRC) | Phase 2 | Status: RECRUITING